Telemedicine Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

The global telemedicine market size was valued at US$ 28 Bn in 2020 and expected to reach US$ 120 billion by 2030 with a CAGR of 14.5% from 2021 to 2030.

Increasing incidences of chronic and other acute diseases, ageing & baby boomers population, technological advancements awareness about the Telehealth services, and increase in healthcare expenditure are projected to drive the Telemedicine market during the forecast period.

Telemedicine is a medical service offered to the patients remotely though telecom or though video conferencing tools. This is referred to as medical practice for the patients with nonphysical presence of patients and healthcare providers. Telemedicine systems are an extension of medical practice in many developed and developing countries with a large rural population. Such remotely located individuals have been greatly benefitted with the presence of telemedicine for their routine healthcare solutions. The overall healthcare standards have improved; this is proved by the increasing life expectancy and decreased mortality rates.

Telemedicine solutions provided by companies range from technologies (product vendors) to healthcare software solution providers. Both the segments are taken under consideration to assess the telemedicine market. This provides a more dynamic scale of study, which has been done considering the global picture of the telemedicine market.

Alliance with Doorstep Diagnostics to Increase Scope of Telemedicine to Drive Market

  • Diagnostic procedures often utilize a significant amount of resources including infrastructure, labor and capital. Many hospitals and medical institutions such as clinics outsource these procedures to diagnostic centers to make the whole process more efficient and cost saving. These services are also directly provided to patient residence upon request. Since medical consultations provided by telemedicine services globally involve directions for diagnostic procedures in cases suggested by medical practitioners, it would be logical to integrate both these homecare solutions to increase the overall patient convenience, and thereby the patient experience. This would boost the telemedicine market as well as the home diagnostics market.
  • Convenience is a major feature of telemedicine and is provided by home diagnostics, thus finding favor with the patients. According to a survey conducted by the U.S. Health magazine, 70% of medical cases can be handled by in-home consultations only. Therefore, this integration would greatly help in increasing patient favor and boost usage.

Dermatology Segment to Dominate Telemedicine Market

  • Based on Speciality segment, the global Telemedicine market has been divided into cardiology, neurology, dermatology, orthopaedics, emergency care, internal medicine, gynecology, and others.
  •  The dermatology segment dominated the global Telemedicine market in 2020 owing to growing prevalence across globe and thus considered to be a leading causes for a visit to a physicians. Moreover, dermatological diseases require personal attention and treatment, which is estimated to boost the demand of the telemedicine services. With privacy being offered to the patient, without having to travel to the hospital, telemedicine in dermatology practice is expected to grow steadily during the forecast period.

Increasing demand for personal healthcare and privacy boosts the market of telemedicine

  • The out of pocket per capita spending on healthcare has increased in past few years across the people across globe. Thus, there have being huge demand in the personal healthcare services amongst growing patient burden. These outpatients had shifted to other forms of patient care i.e., telemedicine, which witnessed constant growth rate.
  • This demonstrated that people were favoring telemedicine and personal healthcare over hospital visits. This trend is expected to continue in the future and telemedicine is likely to replace outpatient hospital visits. Individuals consider hospital infections, location convenience and maintenance of privacy as the primary factors for preferring at home telemedicine solutions. Telemedicine usage, therefore, is expected to rise with the increased demand for personal healthcare.

Increase Tele-nursing and Remote Care to Handle Solutions to Handle Larger Patient Pool

  • The increasing patient pool has created a huge burden on existing healthcare systems of the world. Patient complaints and infections have created mild panic situations in developed and developing countries. A large percentage of these patients represent near normal situations and false alarms. Many of these cases arise due to misinformation regarding medical applications and unnecessary confusion or panic. These problems can be effectively filtered out by trained front level medical practitioners i.e., nursing staff and practice doctors. This filtering can be efficiently implemented to decrease workload and increase the effectiveness and productivity of experienced medical practitioners, who are scarce in many regions. This also improves patient care and paves the way for providing increased attention toward more serious cases that are highly time-bound (i.e. emergency cases).
  •  Since nurses are often well informed about the appropriate expert medical practitioner specializing in a particular case. According to the WHO, stroke accounted for 6 million deaths, and more than 2 million people died of injuries and accidents globally every year. Such emergency cases would highly benefit from timely, accurate and organized telemedicine service, thereby reducing global fatalities.

North America to Dominate Global Market

  • In terms of region, the global Telemedicine market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Telemedicine market in 2020 and the trend is expected to continue during forecast period.
  • North America accounted for major share of the global Telemedicine market in 2020, owing to technological advancements, presence of vast telemedicine providers across region, and remote location of population across United States and Canada. Furthermore, domestic governments offer favorable reimbursement to telemedicine users and the insurance providers is another major driving factor for the telemedicine market in the North America region.
  • The Telemedicine market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2030. This can be attributed to healthy growth of telemedicine in the region including the presence of a large patient population suffering from various types of communicable, non-communicable and lifestyle diseases. Moreover, presence of several low cost domestic manufacturers of mobile communication technology and the growing medical tourism industry in the region paved a new path for the growth in demand for telemedicine installations in various multispecialty hospitals.

Competitive Landscape

  • The global Telemedicine market is fragmented in terms of number of players. Key players in the global market include Agfa-Gevaert Group, Allscripts Healthcare, LLC and/or its affiliates, AMD Global Telemedicine, CISCO Systems Inc, F. Hoffmann-La Roche Ltd., Honeywell HomMed LLC, InTouch Technologies, Inc., BioTelemetry, Inc, Medtronic, OBS Medical Ltd., Siemens Healthcare Private Limited, McKesson Corporation, and other prominent players.

Market Segmentation

By Speciality

    • Cardiology
    • Dermatology
    • Neurology
    • Orthopedics
    • Emergency Care
    • Internal Medicine
    • Gynecology
    • Others

By Process

    • Tele-consultation
    • Tele-surgery
    • Tele-monitoring
    • Tele-education
    • Tele-training
    • Tele-care

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The Telemedicine market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Telemedicine market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Telemedicine market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Telemedicine market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Telemedicine market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Telemedicine capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Telemedicine by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Telemedicine market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Telemedicine market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Telemedicine market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Telemedicine industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Telemedicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Telemedicine market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Telemedicine market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Telemedicine market. These factors have benefited the growth of the global market for Telemedicine. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Telemedicine. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Telemedicine are as follows:

  • History Year: 2017-2020
  • Base Year: 2020
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Telemedicine  Market Analysis and Forecast, 2017–2030

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2.  Disease Prevalence across globe

6. Global Telemedicine  Market Analysis and Forecast, by Speciality

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Telemedicine Market Value Forecast, by Speciality, 2017–2030

        6.2.1. Cardiology

        6.2.2. Dermatology

        6.2.3. Neurology

        6.2.4. Orthopedics

        6.2.5. Emergency Care

        6.2.6. Internal Medicine

        6.2.7. Gynecology 

        6.2.8. Others

    6.3. Global Telemedicine  Market Attractiveness, by Speciality

7. Global Telemedicine  Market Analysis and Forecast, by Process 

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Telemedicine  Market Value Forecast, by Process , 2017–2030

        7.2.1. Tele-consultation

        7.2.2. Tele-Surgery

        7.2.3. Tele-monitoring

        7.2.4. Tele-education

        7.2.5. Tele-training

        7.2.6. Tele-care

        7.2.7. Others 

    7.3. Global Telemedicine  Market Attractiveness, by Process 

8. Global Telemedicine  Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Telemedicine  Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global Telemedicine  Market Attractiveness, by Region

9. North America Telemedicine  Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Telemedicine Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        9.2.1. Cardiology

        9.2.2. Dermatology

        9.2.3. Neurology

        9.2.4. Orthopedics

        9.2.5. Emergency Care

        9.2.6. Internal Medicine

        9.2.7. Gynecology 

        9.2.8. Others

    9.3. North America Telemedicine Market Value (US$ Mn) Forecast, by Process , 2017–2030

        9.3.1. Tele-consultation

        9.3.2. Tele-Surgery

        9.3.3. Tele-monitoring

        9.3.4. Tele-education

        9.3.5. Tele-training

        9.3.6. Tele-care

        9.3.7. Others 

    9.4. North America Telemedicine  Market Value (US$ Mn) Forecast, by Country, 2017–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Telemedicine  Market Attractiveness Analysis 

        9.5.1. By Type

        9.5.2. By Process 

        9.5.3. By Country

10. Europe Telemedicine  Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Telemedicine Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        10.2.1. Cardiology

        10.2.2. Dermatology

        10.2.3. Neurology

        10.2.4. Orthopedics

        10.2.5. Emergency Care

        10.2.6. Internal Medicine

        10.2.7. Gynecology 

        10.2.8. Others

    10.3. Europe Telemedicine Market Value (US$ Mn) Forecast, by Process , 2017–2030

        10.3.1. Tele-consultation

        10.3.2. Tele-Surgery

        10.3.3. Tele-monitoring

        10.3.4. Tele-education

        10.3.5. Tele-training

        10.3.6. Tele-care

        10.3.7. Others 

    10.4. Europe Telemedicine  Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe 

    10.5. Europe Telemedicine  Market Attractiveness Analysis 

        10.5.1. By Type

        10.5.2. By Process 

        10.5.3. By Country/Sub-region

11. Asia Pacific Telemedicine  Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        11.2.1. Cardiology

        11.2.2. Dermatology

        11.2.3. Neurology

        11.2.4. Orthopedics

        11.2.5. Emergency Care

        11.2.6. Internal Medicine

        11.2.7. Gynecology 

        11.2.8. Others

    11.3. Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Process , 2017–2030

        11.3.1. Tele-consultation

        11.3.2. Tele-Surgery

        11.3.3. Tele-monitoring

        11.3.4. Tele-education

        11.3.5. Tele-training

        11.3.6. Tele-care

        11.3.7. Others 

    11.4. Asia Pacific Telemedicine  Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Telemedicine  Market Attractiveness Analysis 

        11.5.1. By Type

        11.5.2. By Process 

        11.5.3. By Country/Sub-region

12. Latin America Telemedicine  Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Telemedicine Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        12.2.1. Cardiology

        12.2.2. Dermatology

        12.2.3. Neurology

        12.2.4. Orthopedics

        12.2.5. Emergency Care

        12.2.6. Internal Medicine

        12.2.7. Gynecology 

        12.2.8. Others

    12.3. Latin America Telemedicine Market Value (US$ Mn) Forecast, by Process , 2017–2030

        12.3.1. Tele-consultation

        12.3.2. Tele-Surgery

        12.3.3. Tele-monitoring

        12.3.4. Tele-education

        12.3.5. Tele-training

        12.3.6. Tele-care

        12.3.7. Others 

    12.4. Latin America Telemedicine  Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America Latin America 

    12.5. Latin America Telemedicine  Market Attractiveness Analysis 

        12.5.1. By Type

        12.5.2. By Process 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Telemedicine  Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Telemedicine  Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        13.2.1. Cardiology

        13.2.2. Dermatology

        13.2.3. Neurology

        13.2.4. Orthopedics

        13.2.5. Emergency Care

        13.2.6. Internal Medicine

        13.2.7. Gynecology 

        13.2.8. Others

    13.3. Middle East & Africa Telemedicine  Market Value (US$ Mn) Forecast, by Speciality, 2017–2030

        13.3.1. Tele-consultation

        13.3.2. Tele-Surgery

        13.3.3. Tele-monitoring

        13.3.4. Tele-education

        13.3.5. Tele-training

        13.3.6. Tele-care

        13.3.7. Others 

    13.4. Middle East & Africa Telemedicine  Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa 

    13.5. Middle East & Africa Telemedicine  Market Attractiveness Analysis 

        13.5.1. By Type

        13.5.2. By Process 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. Agfa-Gevaert Group

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. Allscripts Healthcare, LLC and/or its affiliates

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. AMD Global Telemedicine, Inc 

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. CISCO Systems Inc

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. F. Hoffmann-La Roche Ltd., 

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis 

        14.3.6. Honeywell HomMed LLC 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis

        14.3.7. InTouch Technologies, Inc 

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Growth Strategies

            14.3.7.3. SWOT Analysis

        14.3.8. BioTelemetry, Inc, 

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Growth Strategies

            14.3.8.3. SWOT Analysis

        14.3.9. Medtronic 

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Growth Strategies

            14.3.9.3. SWOT Analysis

        14.3.10. OBS Medical Ltd

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Growth Strategies

            14.3.10.3. SWOT Analysis

        14.3.11. Siemens Healthcare Private Limited

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Growth Strategies

            14.3.11.3. SWOT Analysis

        14.3.12. McKesson Corporation 

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Growth Strategies

            14.3.12.3. SWOT Analysis

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Telemedicine Market, By Component Type

7.1.  Telemedicine Market, by Component Type, 2020-2027

7.1.1.    Product

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Services

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Telemedicine Market, By Tecnhology Type

8.1.  Telemedicine Market, By Tecnhology Type, 2020-2027

8.1.1.    Store and Forward

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Real Time

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Telemedicine Market, By Application Type

9.1.  Telemedicine Market, by Application Type, 2020-2027

9.1.1.    Teleradiology

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Telepsychiatry

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Telepathology

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Teledermatology

9.1.4.1.        Market Revenue and Forecast (2016-2027)

9.1.5.    Telecardiology

9.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Telemedicine Market, By Delivery Mode Type

10.1.        Telemedicine Market, by Delivery Mode Type, 2020-2027

10.1.1.  Web/Mobile

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Call Centers

10.1.2.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global Telemedicine Market, By Type

11.1.        Telemedicine Market, By Type, 2020-2027

11.1.1.  Tele-hospital

11.1.1.1.      Market Revenue and Forecast (2016-2027)

11.1.2.  Tele-home

11.1.2.1.      Market Revenue and Forecast (2016-2027)

Chapter 12.      Global Telemedicine Market, By End-Use

12.1.        Telemedicine Market, By Tecnhology Type, 2020-2027

12.1.1.  Providers

12.1.1.1.      Market Revenue and Forecast (2016-2027)

12.1.2.  Payers

12.1.2.1.      Market Revenue and Forecast (2016-2027)

12.1.3.  Patients

12.1.3.1.      Market Revenue and Forecast (2016-2027)

12.1.4.  Other

12.1.4.1.      Market Revenue and Forecast (2016-2027)

Chapter 13.      Global Telemedicine  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, by Component (2016-2027)

13.1.2.  Market Revenue and Forecast, By Tecnhology (2016-2027)

13.1.3.  Market Revenue and Forecast, by Application (2016-2027)

13.1.4.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.1.5.  Market Revenue and Forecast, By Type (2016-2027)

13.1.6.  Market Revenue and Forecast, By End-Use (2016-2027)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, by Component (2016-2027)

13.1.7.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.1.7.3.      Market Revenue and Forecast, by Application (2016-2027)

13.1.7.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.1.8.  Market Revenue and Forecast, By Type (2016-2027)

13.1.8.1.      Market Revenue and Forecast, By End-Use (2016-2027)

13.1.9.  Rest of North America

13.1.9.1.      Market Revenue and Forecast, by Component (2016-2027)

13.1.9.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.1.9.3.      Market Revenue and Forecast, by Application (2016-2027)

13.1.9.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.1.10.               Market Revenue and Forecast, By Type (2016-2027)

13.1.11.               Market Revenue and Forecast, By End-Use (2016-2027)

13.1.11.1.    

13.2.        Europe

13.2.1.  Market Revenue and Forecast, by Component (2016-2027)

13.2.2.  Market Revenue and Forecast, By Tecnhology (2016-2027)

13.2.3.  Market Revenue and Forecast, by Application (2016-2027)

13.2.4.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.2.5.  Market Revenue and Forecast, By Type (2016-2027)

13.2.6.  Market Revenue and Forecast, By End-Use (2016-2027)

13.2.7.   

13.2.8.  UK

13.2.8.1.      Market Revenue and Forecast, by Component (2016-2027)

13.2.8.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.2.8.3.      Market Revenue and Forecast, by Application (2016-2027)

13.2.9.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.2.10.               Market Revenue and Forecast, By Type (2016-2027)

13.2.10.1.   Market Revenue and Forecast, By End-Use (2016-2027)

13.2.11.               Germany

13.2.11.1.   Market Revenue and Forecast, by Component (2016-2027)

13.2.11.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.2.11.3.   Market Revenue and Forecast, by Application (2016-2027)

13.2.12.               Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.2.13.               Market Revenue and Forecast, By Type (2016-2027)

13.2.14.               Market Revenue and Forecast, By End-Use (2016-2027)

13.2.14.1.    

13.2.15.               France

13.2.15.1.   Market Revenue and Forecast, by Component (2016-2027)

13.2.15.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.2.15.3.   Market Revenue and Forecast, by Application (2016-2027)

13.2.15.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.2.16.               Market Revenue and Forecast, By Type (2016-2027)

13.2.16.1.   Market Revenue and Forecast, By End-Use (2016-2027)

13.2.17.               Rest of Europe

13.2.17.1.   Market Revenue and Forecast, by Component (2016-2027)

13.2.17.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.2.17.3.   Market Revenue and Forecast, by Application (2016-2027)

13.2.17.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.2.18.               Market Revenue and Forecast, By Type (2016-2027)

13.2.18.1.   Market Revenue and Forecast, By End-Use (2016-2027)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, by Component (2016-2027)

13.3.2.  Market Revenue and Forecast, By Tecnhology (2016-2027)

13.3.3.  Market Revenue and Forecast, by Application (2016-2027)

13.3.4.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.3.5.  Market Revenue and Forecast, By Type (2016-2027)

13.3.6.  Market Revenue and Forecast, By End-Use (2016-2027)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, by Component (2016-2027)

13.3.7.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.3.7.3.      Market Revenue and Forecast, by Application (2016-2027)

13.3.7.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.3.8.  Market Revenue and Forecast, By Type (2016-2027)

13.3.9.  Market Revenue and Forecast, By End-Use (2016-2027)

13.3.10.               China

13.3.10.1.   Market Revenue and Forecast, by Component (2016-2027)

13.3.10.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.3.10.3.   Market Revenue and Forecast, by Application (2016-2027)

13.3.10.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.3.11.               Market Revenue and Forecast, By Type (2016-2027)

13.3.11.1.   Market Revenue and Forecast, By End-Use (2016-2027)

13.3.12.               Japan

13.3.12.1.   Market Revenue and Forecast, by Component (2016-2027)

13.3.12.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.3.12.3.   Market Revenue and Forecast, by Application (2016-2027)

13.3.12.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.3.12.5.   Market Revenue and Forecast, By Type (2016-2027)

13.3.12.6.   Market Revenue and Forecast, By End-Use (2016-2027)

13.3.13.               Rest of APAC

13.3.13.1.   Market Revenue and Forecast, by Component (2016-2027)

13.3.13.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.3.13.3.   Market Revenue and Forecast, by Application (2016-2027)

13.3.13.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.3.13.5.   Market Revenue and Forecast, By Type (2016-2027)

13.3.13.6.   Market Revenue and Forecast, By End-Use (2016-2027)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, by Component (2016-2027)

13.4.2.  Market Revenue and Forecast, By Tecnhology (2016-2027)

13.4.3.  Market Revenue and Forecast, by Application (2016-2027)

13.4.4.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.4.5.  Market Revenue and Forecast, By Type (2016-2027)

13.4.6.  Market Revenue and Forecast, By End-Use (2016-2027)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, by Component (2016-2027)

13.4.7.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.4.7.3.      Market Revenue and Forecast, by Application (2016-2027)

13.4.7.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.4.8.  Market Revenue and Forecast, By Type (2016-2027)

13.4.9.  Market Revenue and Forecast, By End-Use (2016-2027)

13.4.10.               North Africa

13.4.10.1.   Market Revenue and Forecast, by Component (2016-2027)

13.4.10.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.4.10.3.   Market Revenue and Forecast, by Application (2016-2027)

13.4.10.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.4.11.               Market Revenue and Forecast, By Type (2016-2027)

13.4.12.               Market Revenue and Forecast, By End-Use (2016-2027)

13.4.13.               South Africa

13.4.13.1.   Market Revenue and Forecast, by Component (2016-2027)

13.4.13.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.4.13.3.   Market Revenue and Forecast, by Application (2016-2027)

13.4.13.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.4.13.5.   Market Revenue and Forecast, By Type (2016-2027)

13.4.13.6.   Market Revenue and Forecast, By End-Use (2016-2027)

13.4.14.               Rest of MEA

13.4.14.1.   Market Revenue and Forecast, by Component (2016-2027)

13.4.14.2.   Market Revenue and Forecast, By Tecnhology (2016-2027)

13.4.14.3.   Market Revenue and Forecast, by Application (2016-2027)

13.4.14.4.   Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.4.14.5.   Market Revenue and Forecast, By Type (2016-2027)

13.4.14.6.   Market Revenue and Forecast, By End-Use (2016-2027)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, by Component (2016-2027)

13.5.2.  Market Revenue and Forecast, By Tecnhology (2016-2027)

13.5.3.  Market Revenue and Forecast, by Application (2016-2027)

13.5.4.  Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.5.5.  Market Revenue and Forecast, By Type (2016-2027)

13.5.6.  Market Revenue and Forecast, By End-Use (2016-2027)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, by Component (2016-2027)

13.5.7.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.5.7.3.      Market Revenue and Forecast, by Application (2016-2027)

13.5.7.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.5.8.  Market Revenue and Forecast, By Type (2016-2027)

13.5.8.1.      Market Revenue and Forecast, By End-Use (2016-2027)

13.5.9.  Rest of LATAM

13.5.9.1.      Market Revenue and Forecast, by Component (2016-2027)

13.5.9.2.      Market Revenue and Forecast, By Tecnhology (2016-2027)

13.5.9.3.      Market Revenue and Forecast, by Application (2016-2027)

13.5.9.4.      Market Revenue and Forecast, by Delivery Mode (2016-2027)

13.5.9.5.      Market Revenue and Forecast, By Type (2016-2027)

13.5.9.6.      Market Revenue and Forecast, By End-Use (2016-2027)

Chapter 14.  Company Profiles

14.1.              MDlive Inc.

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              SteadyMD Inc.

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Maven, Inc.

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              iCliniq

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              HealthTap, Inc.

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              BioTelemetry, Inc.

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              American Well

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              CVS Health

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              Synapse Medicine.

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Practo

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

14.11.           Teladoc Health, Inc.

14.11.1.               Company Overview

14.11.2.               Product Offerings

14.11.3.               Financial Performance

14.11.4.               Recent Initiatives

14.12.           Doctor On Demand, Inc.

14.12.1.               Company Overview

14.12.2.               Product Offerings

14.12.3.               Financial Performance

14.12.4.               Recent Initiatives

14.13.           AMD Global Telemedicine.

14.13.1.               Company Overview

14.13.2.               Product Offerings

14.13.3.               Financial Performance

14.13.4.               Recent Initiatives

14.14.           Aerotel Medical Systems (1998) Ltd.

14.14.1.               Company Overview

14.14.2.               Product Offerings

14.14.3.               Financial Performance

14.14.4.               Recent Initiatives

14.15.           Plantronics, Inc. (Polycom)

14.15.1.               Company Overview

14.15.2.               Product Offerings

14.15.3.               Financial Performance

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers